In addition, Gal-9 protein was highly expressed on the cell surface of AML cells, especially when relapse after HSCT compared with healthy donor derived mononuclear bone marrow cells and AML cells without HSCT in clinical practice (Figure 1E; Table 1). Here, LGALS9 is linked to acute myeloid leukemia.